An increase in the proportion of intra-tumoral CD103+ and TRM-like tumor-infiltrating lymphocytes is associated with improved responses to immune checkpoint inhibition as well as improved survival in a variety of tumors, including melanoma, lung cancer, head and neck, and bladder cancer25,29,30,34. This evidence concerns the gene ITGAE and lung carcinoma.